CLARITY PHARMACEUTICALS LTD

Press Releases Clarity Pharmaceuticals Ltd

Equities

CU6

AU0000165375

Market Closed - Australian S.E. Other stock markets 11:40:23 29/05/2024 am IST			5-day change	1st Jan Change
4.6 ^AUD	+2.22%		+13.02%	+142.11%

24/04	Clarity Pharmaceuticals Completes AU$10.8 Million Retail Entitlement Offer	MT
04/04	Clarity Pharmaceuticals Signs Supply Agreement with NorthStar Medical Radioisotopes	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort	30/11	AQ
Clarity and PSI kick off SAR-bisPSMA Phase III	27/23/27	AQ
Clarity Pharmaceuticals - First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial	04/23/04	AQ
Clarity Pharmaceuticals - First participant treated in the highest dose cohort of neuroblastoma trial	28/23/28	AQ
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial	28/23/28	AQ
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial	25/23/25	AQ
Clarity Pharmaceuticals - Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer	05/23/05	AQ
Clarity establishes a US Center of Excellence for Targeted Copper Theranostics	29/23/29	AQ
Clarity commences COMBAT theranostic prostate cancer trial in the US	21/23/21	AQ
Clarity Pharmaceuticals : Application for quotation of securities - CU6	06/22/06	PU
Clarity Pharmaceuticals : Governance & Trading Policy Update	09/22/09	PU
Clarity Pharmaceuticals : Notification regarding unquoted securities - CU6	01/22/01	PU
Clarity Pharmaceuticals : Application for quotation of securities - CU6	21/22/21	PU
Clarity Pharmaceuticals : Application for quotation of securities - CU6	14/22/14	PU
Clarity Pharmaceuticals : - Investor Presentation 03-03-2022	03/22/03	PU
Clarity Pharmaceuticals : Half Yearly Report	28/22/28	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer